The acute dialysis quality initiative - Part VII: Fluid composition and management in CRRT

Advances in Renal Replacement Therapy

Volumn 9, Issue 4, 2002, Pages 282-289

  Schetz, Miet ^a   Leblanc, Martine ^b   Murray, Patrick T ^c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Buffer; Continuous renal replacement therapy; Electrolytes; Fluid balance; Predilution

Indexed keywords

BICARBONATE; CITRIC ACID; ELECTROLYTE; GLUCOSE;

ANTICOAGULATION; BODY TEMPERATURE; CHEMICAL COMPOSITION; CRITICAL ILLNESS; DIALYSIS; ELECTROLYTE BALANCE; HEALTH CARE QUALITY; HUMAN; LACTIC ACIDOSIS; LIVER FAILURE; PH MEASUREMENT; PRIORITY JOURNAL; REVIEW; ULTRAFILTRATION;

BUFFERS; DIALYSIS SOLUTIONS; HUMANS; PRACTICE GUIDELINES; QUALITY ASSURANCE, HEALTH CARE; RENAL DIALYSIS;

EID: 0036775279     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1053/jarr.2002.35572     Document Type: Note

References (71)

1. Kaplan AA, Longnecker RE, Folkert VW. Continuous arteriovenous hemofiltration. A report of six months' experience. Ann Intern Med 100:358-367, 1984
2. Sigler MH, Teehan BP. Solute transport in continuous hemodialysis: A new treatment for acute renal failure. Kidney Int 32:562-571, 1987
3. Bellomo R, Ernest D, Love J, et al: Continuous arteriovenous haemodiafiltration: Optimal therapy for acute renal failure in an intensive care setting? Aust NZ L Med 20:237-242, 1990
4. Pataca MI, Ramesh BR, Parmer A, et al: Continuous arteriovenous haemodialysis in severe combined renal and respiratory failure. Blood Purif 10:262-268, 1992
5. Barton IK, Hilton PJ: Veno-venous haemofiltration in the intensive care unit. Clin Intens Care 4:16-22, 1993
6. Bellomo R, Martin H, Parkin G, et al: Continuous arteriovenous haemodiafiltration in the critically ill: Influence on major nutrient balances. Intensive Care Med 17:399-402, 1991
7. Bonnardeaux A, Pichette V, Ouimet D, et al: Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis. Am J Kidney Dis 19:31-38, 1992
8. Bellomo R, Colman PG, Caudwell J, et al: Acute continuous hemofiltration with dialysis: Effect on insulin concentrations and glycemic control in critically ill patients. Crit Care Med 20:1672-1676, 1992
9. Monaghan R, Watters JM, Clancey SM, et al: Uptake of glucose during continuous arteriovenous hemofiltration. Crit Care Med 21:1159-1163, 1993
10. Frankenfield DC, Reynolds HN, Badellino MM, et al: Glucose dynamics during continuous hemodiafiltration and total parenteral nutrition. Intensive Care Med 21:1016-1022, 1995
11. Lopot F, Valek A: Pre-vs. post-dilutional hemofiltration. Clin Nephrol 12:69-73, 1979
12. Ledebo I: Predilution hemofiltration: A new technology applied to an old therapy. Int J Artif Organs 18:735-742, 1995
13. Ficheux A, Argiles A, Bosc JY, et al: Analysis of the influence of the infusion site on dialyser clearances measured in an in vitro system mimicking haemodialysis and haemodiafiltration. Blood Purif 17:10-18, 1999
14. Brunet S, Leblanc M, Geadah D, et al: Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 34:486-492, 1999
15. Leblanc M, Moreno L, Robinson OP, et al: Bicarbonate dialysate for continuous renal replacement therapy in intensive care unit patients with acute renal failure. Am J Kidney Dis 26:910-917, 1995
16. Kierdorf H, Leue C, Heintz B, et al: Continuous venovenous hemofiltration in ARF: Is a bicarbonate or lactate-buffered solution better? Contrib Nephrol 116: 38-47, 1995
17. Morgera S, Heering P, Szentandrasi T, et al: Comparison of a lactate-versus acetate-based hemofiltration replacement fluid in patients with acute renal failure. Ren Fail 19:155-164, 1997
18. Thomas AN, Guy JM, Kishen R, et al: Comparison of lactate and bicarbonate buffered haemofiltration fluids: Use in critically ill patients. Nephrol Dial Transplant 12:1212-1217, 1997
19. Heering P, Ivens K, Thumer O, et al: Acid-base balance and substitution fluid during continuous hemofiltration. Kidney Int 56:S37-40, 1999 (suppl)
20. Zimmerman D, Cotman P, Ting R, et al: Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: Prospective cross-over comparison with a lactate buffered solution. Nephrol Dial Transplant 14:2387-2391, 1999
21. Veech RL: The untoward effects of the anions of dialysis fluid. Kidney Int 34:587-597, 1988
22. Barton IK, Streather CP, Hilton PJ, et al: Successful treatment of severe lactic acidosis by haemofiltration using a bicarbonate-based replacement fluid. Nephrol Dial Transplant 6:368-370, 1991
23. Forni LG, Darling K, Evans M, et al: Lactate-intolerance with continuous haemofiltration: The role of bicarbonate-buffered haemofiltration. Clin Intens Care 9:40-42, 1998
24. Hilton PJ, Taylor J, Forni LG, et al: Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis. Quart J Med 91:279-283, 1998
25. Reynolds HN, Belzberg H, Connelly J: Hyperlactatemia in patients undergoing continuous arteriovenous hemofiltration with dialysis. Crit Care Med 18:582, 1990 (letter)
26. Davenport A, Will EJ, Davison AM: Paradoxical increase in arterial hydrogen ion concentration in patients with hepatorenal failure given lactate-based fluids. Nephrol Dial Transplant 5:342-346, 1990
27. Davenport A, Aulton K, Payne RB, et al: Hyperlactatemia and increasing metabolic acidosis in hepatorenal failure treated by hemofiltration. Ren Fail 12:99-101, 1990
28. Davenport A, Will EJ, Davison AM: Hyperlactataemia and metabolic acidosis during haemofiltration using lactate-buffered fluids. Nephron 59:461-465, 1991
29. Mehta RL, McDonald BR, Aguilar MM, et al: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38: 976-981, 1990
30. Ward DM, Mehta RL: Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 43:S237-244, 1993 (suppl)
31. Palsson R, Niles JL: Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55:1991-1997, 1999
32. Kirschbaum B, Galishoff M, Reines HD: Lactic acidosis treated with continuous hemodiafiltration and regional citrate anticoagulation. Crit Care Med 20:349-353, 1992
33. Matamis D, Tsagourias M, Koletsos K, et al: Influence of continuous haemofiltration-related hypothermia on haemodynamic variables and gas exchange in septic patients. Intensive Care Med 20:431-436, 1994
34. Manns M, Maurer E, Steinbach B, et al: Thermal energy balance during in vitro continuous veno-venous hemofiltration. ASAIO J 44:M601-605, 1998
35. Yagi N, Leblanc M, Sakai K, et al: Cooling effect of continuous renal replacement therapy in critically ill patients. Am J Kidney Dis 32:1023-1030, 1998
36. Golper TA, Leone M: Backtransport of dialysate solutes during in vitro continuous arteriovenous hemodialysis. Blood Purif 7:223-229, 1989
37. Ronco C: Backfiltration in clinical dialysis: Nature of the phenomenon, mechanisms and possible solutions. Int J Artif Organs 13:11-21, 1990
38. Ronco C, Brendolan A, Feriani M, et al: A new scintigraphic method to characterize ultrafiltration in hollow fiber dialyzers. Kidney Int 41:1383-1393, 1992
39. Lonnemann G, Behme T, Lenzner B, et al: Permeability of dialyzer membranes to TNFa-inducing substances derived from water bacteria. Kidney Int 42:61-68, 1992
40. Pereira BJ, Snodgrass BR, Hogan PJ, et al: Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes. Kidney Int 47:603-610, 1995
41. Bommer J, Becker KP, Urbaschek R: Potential transfer of endotoxin across high-flux polysulfone membranes. J Am Soc Nephrol 7:883-888, 1996
42. Krautzig S, Linnenweber S, Schindler R, et al: New indicators to evaluate bacteriological quality of the dialysis fluid and the associated inflammatory response in ESRD patients. Nephrol Dial Transplant 11:87-91, 1996 (suppl)
43. Panichi V, Tetta C, Rindi P, et al: Plasma C-reactive protein is linked to backfiltration associated interleukin-6 production. ASAIO J 44:M415-417, 1998
44. Lonnemann G: Should ultra-pure dialysate be mandatory? Nephrol Dial Transplant 15:55-59, 2000 (suppl)
45. Alamartine E, de Filippis JP, Toulon J, et al: On-line continuous venovenous hemodiafiltration: A technique for the control of ultrafiltration and convection during continuous renal replacement therapy. Ren Fail 16:707-714, 1994
46. Canaud B, Bosc JY, Leray-Moragues H, et al: On-line haemodiafiltration. Safety and efficacy in long-term clinical practice. Nephrol Dial Transplant 15:60-67, 2000
47. Vaslaki L, Karatson A, Voros P, et al: Can sterile and pyrogen-free on-line substitution fluid be routinely delivered? A multicentric study on the microbiological safety of on-line haemodiafiltration. Nephrol Dial Transplant 15:74-78, 2000
48. Mehta RL: Fluid management in continuous renal replacement therapy. Semin Dial 9:140-144, 1996
49. Lauer A, Saccaggi A, Ronco C, et al: Continuous arteiovenous hemofiltration in the critically ill patient. Clinical use and operational characteristics. Ann Intern Med 99:455-460, 1983
50. Roberts M, Winney RJ: Errors in fluid balance with pump control of continuous hemodialysis. Int J Artif Organs 10:292-308, 1992
51. Bosworth C, Swann S, Paganini E: Evaluation of the IMED Gemini PC2 volumetric infusion pumps in extracorporeal continuous therapy circuits. Dial Transplant 19:26-28, 1990
52. Jenkins R, Harrison H, Chen B, et al: Accuracy of intravenous infusion pumps in continuous renal replacement therapies. ASAIO J 38:808-810, 1992
53. Ronco C, Brendolan A, Bellomo R: Current technology for continuous renal replacement therapies, in Claudio Ronco, Rinaldo Bellomo (eds). Critical Care Nephrology. Dordrecht, The Netherlands, Kluwer Academic Publishers, 1998, pp 1269-1308
54. Russell JA, Phang PT: The oxygen delivery/consumption controversy. Approaches to management of the critically ill. Am J Respir Crit Care Med 149:533-537, 1994
55. Schumacker PT: Oxygen supply dependency in critical illness: An evolving understanding. Intensive Care Med 24:97-99, 1998
56. Canaud B, Leray-Moragues H, Garred LJ, et al: Slow isolated ultrafiltration for the treatment of congestive heart failure. Am J Kid Dis 28:S67-S73, 1996 (suppl)
57. Lowell JA, Schifferdecker C, Driscoll DF, et al: Postoperative fluid overload: Not a benign problem. Crit Care Med 18:728-733, 1990
58. Schuster DP: The case for and against fluid restriction and occlusion pressure reduction in adult respiratory distress syndrome. New Horizons 1:478-488, 1993
59. Alsous F, Khamiees M, DeGirolamo A, et al: Negative fluid balance predicts survival in patients with septic shock. A retrospective pilot study. Chest 117:1749-1754, 2000
60. Mitchell JP, Schuller D, Calandrino FS, et al: Improved outcomes based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis 145:990-998, 1992
61. Inoue T, Sakai Y, Morooka S, et al: Hemofiltration as treatment for patients with refractory congestive heart failure. Clin Cardiol 15:514-518, 1992
62. Laggner AN, Druml W, Lenz K, et al: Influence of ultrafiltration/hemofiltration on extravascular lung water. Contrib Nephrol 93:65-70, 1991
63. Bellomo R, Farmer M, Boyce N: Combined acute respiratory and renal failure: Management by continuous hemodiafiltration. Resuscitation 28:123-131, 1994
64. Bagshaw ON, Anaes FR, Hutchinson A: Continuous arteriovenous haemofiltration and respiratory function in multiple organ systems failure. Intensive Care Med 18:334-338, 1992
65. Lowrie LH: Renal replacement therapies in pediatric multiple organ dysfunction syndrome. Pediatr Nephrol 14:6-12, 2000
66. DiCarlo JV, Dudley TE, Sherboitie JR, et al: Continuous arteriovenous hemofiltration/dialysis improves pulmonary gas exchange in children with multiple organ system failure. Crit Care Med 18:822-826, 1990
67. Kruger I, Jacobi C, Landwehr P: Effects of continuous venovenous hemofiltration on pulmonary function and hemodynamics in postoperative septic multiorgan failure. Contrib Nephrol 116:108-111, 1995
68. Ronco C, Brendolan A, Bellomo R: Online monitoring in continuous renal replacement therapies. Kidney Int 56:S8-S14, 1999 (suppl)
69. Barenbrock M, Hausberg M, Matzkies F, et al: Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int 58:1751-1757, 2000
70. McLean AG, Davenport A, Cox D, et al: Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction. Kidney Int 58:1765-1772, 2000
71. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in critically ill patients. New Engl J Med 345:1359-1367, 2001